Page last updated: 2024-08-23

moxalactam and Infant, Newborn, Diseases

moxalactam has been researched along with Infant, Newborn, Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bégué, P; Lasfargues, G; Quinet, B; Quiniou, F; Safran, C1
McCracken, GH; Schaad, UB; Thomas, ML; Threlkeld, N1
Fujii, R; Hashira, S; Maruyama, S; Oka, T; Sanae, N; Sunakawa, K; Takimoto, M; Tojo, M; Tsuchida, A; Yoshioka, H1
de Louvois, J; James, J; Mulhall, A2
Eichenwald, HF1

Other Studies

6 other study(ies) available for moxalactam and Infant, Newborn, Diseases

ArticleYear
Comparative pharmacokinetics of four new cephalosporins: moxalactam, cefotaxime, cefoperazone and ceftazidime in neonates.
    Developmental pharmacology and therapeutics, 1984, Volume: 7 Suppl 1

    Topics: Cefoperazone; Cefotaxime; Ceftazidime; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Moxalactam

1984
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    The Journal of pediatrics, 1981, Volume: 98, Issue:1

    Topics: Bacterial Infections; Brain Abscess; Cephalosporins; Cephamycins; Escherichia coli Infections; Female; Half-Life; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Parenteral; Injections, Intramuscular; Kinetics; Klebsiella Infections; Male; Meningitis; Moxalactam; Salmonella Infections; Serratia marcescens

1981
[Pharmacokinetic and clinical studies of latamoxef (moxalactam) in neonates and premature infants].
    The Japanese journal of antibiotics, 1984, Volume: 37, Issue:6

    Topics: Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Infusions, Parenteral; Injections, Intravenous; Kinetics; Meningitis, Meningococcal; Moxalactam; Staphylococcus aureus; Streptococcus pneumoniae; Urinary Tract Infections

1984
Moxalactam as an alternative to gentamicin in the treatment of clinically infected neonates.
    Developmental pharmacology and therapeutics, 1984, Volume: 7 Suppl 1

    Topics: Gentamicins; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Kinetics; Moxalactam

1984
Antibiotic drug therapy in the newborn.
    Pediatric pharmacology (New York, N.Y.), 1983, Volume: 3, Issue:3-4

    Topics: Anti-Bacterial Agents; Drug Evaluation; Extracellular Space; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Moxalactam; Protein Binding; Tissue Distribution

1983
Latamoxef and the newborn.
    Archives of disease in childhood, 1984, Volume: 59, Issue:4

    Topics: Bacterial Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Kinetics; Moxalactam; Prospective Studies

1984